‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

1 hour ago 1
ARTICLE AD BOX
Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs
Read Entire Article
  1. Homepage
  2. category-label-
  3. ‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

Related

HSBC quarterly profit soars to $10.1bn

HSBC quarterly profit soars to $10.1bn

1 hour ago 0
Revolut chief Nik Storonsky sued by broker over €350mn superyacht

Revolut chief Nik Storonsky sued by broker over €350mn super...

1 hour ago 0
Inside Google’s $200bn Wall Street finance machine for Anthropic

Inside Google’s $200bn Wall Street finance machine for Anthr...

1 hour ago 0
RIGHT SIDEBAR TOP AD

Trending

1. mitch mcconnell
2. adam sandler
3. davante adams
4. the amazing spider-man
5. rihanna
6. oregon fires
7. jasson dominguez
8. eshop sale
9. harry truman
10. chevron

Popular

Netflix investors are getting squeamish as Amazon makes inroads in the battle for streaming dominance

Netflix investors are getting squeamish as Amazon makes inro...

1 month ago 7
Some singles now expect their dates to pay for their Ubers while gas prices are so high

Some singles now expect their dates to pay for their Ubers w...

1 month ago 5
Jane Street Plans New Data Center as Compute Power Runs Scarce

Jane Street Plans New Data Center as Compute Power Runs Scar...

1 month ago 5
‘This is not a flash in the pan’ — why value stocks are beating growth by such a wide margin

‘This is not a flash in the pan’ — why value stocks are beat...

1 month ago 5
Here’s how SpaceX is pitching its IPO to everyday investors

Here’s how SpaceX is pitching its IPO to everyday investors

1 month ago 4
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexus Financial News 2026. All rights are reserved